Alnylam Pharmaceuticals
Biotechnology Research
Cambridge, Massachusetts 197,138 followers
Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach.
Developing an innovative new class of medicines requires true innovators and passionate dreamers.
Our employees have chosen to do what is hard and are relentless in the pursuit of new treatments for people living with rare diseases.
Alnylam is the Leading RNAi Therapeutics Company
We are the leading RNAi therapeutics company and have pioneered this entirely new class of medicines. Based on Nobel Prize-winning science, RNAi therapeutics are a powerful approach for the treatment of a wide range of diseases. Since our founding, we have been regularly recognized as a leader and innovator, including being a Science Magazine Top Employer (2019-23), Boston Globe Top Place to Work (2015-23), a Fast Company Best Workplace for Innovators (21-23) and a LinkedIn Top Employer 2024.
Learn More about Alynlam Visit the Alnylam NewsroomAt the Forefront of What's Next for Patients, and Perhaps Your Career Also
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 2,500 employees are building a diverse, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
Careers See Office LocationsAlnylam's Culture & Values
Our employees come from diverse backgrounds, representing dozens of countries and more than 20 languages. We have strong values that guide who we hire, what we recognize, what we value, and that serve as the foundation of our culture. Our core values are: - Passion for Excellence - Fiercely Innovative - Commitment to People - Open Culture - Purposeful Urgency
Learn about Our Culture Learn about DE&I at AlnylamCompany photos
Similar pages
Browse jobs
Stock
ALNY
NASDAQ
20 minutes delay
$257.76
3.02 (1.186%)
- Open
- 256
- Low
- 253.82
- High
- 257.97
Data from Refinitiv
See more info on